Chong Kun Dang Pharmaceutical Corp
KRX:185750
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
94 000
133 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Chong Kun Dang Pharmaceutical Corp
Income Statement
Earnings Waterfall
Chong Kun Dang Pharmaceutical Corp
|
Revenue
|
1.7T
KRW
|
|
Cost of Revenue
|
-1T
KRW
|
|
Gross Profit
|
655.6B
KRW
|
|
Operating Expenses
|
-418.8B
KRW
|
|
Operating Income
|
236.8B
KRW
|
|
Other Expenses
|
-24B
KRW
|
|
Net Income
|
212.8B
KRW
|
Income Statement
Chong Kun Dang Pharmaceutical Corp
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue |
1 373 018
N/A
|
1 411 508
+3%
|
1 453 159
+3%
|
1 488 345
+2%
|
1 512 154
+2%
|
1 542 134
+2%
|
1 561 851
+1%
|
1 669 404
+7%
|
1 665 726
0%
|
1 666 522
+0%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(864 886)
|
(898 595)
|
(928 525)
|
(945 705)
|
(959 333)
|
(979 522)
|
(989 778)
|
(1 007 203)
|
(1 006 471)
|
(1 010 926)
|
|
| Gross Profit |
508 132
N/A
|
512 913
+1%
|
524 634
+2%
|
542 639
+3%
|
552 821
+2%
|
562 612
+2%
|
572 073
+2%
|
662 202
+16%
|
659 254
0%
|
655 597
-1%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(410 196)
|
(419 681)
|
(428 250)
|
(432 733)
|
(440 387)
|
(432 117)
|
(425 167)
|
(415 602)
|
(413 315)
|
(418 817)
|
|
| Selling, General & Administrative |
(242 827)
|
(250 797)
|
(255 388)
|
(250 320)
|
(254 763)
|
(255 910)
|
(259 895)
|
(268 423)
|
(272 210)
|
(276 098)
|
|
| Research & Development |
(162 135)
|
(163 382)
|
(167 075)
|
(176 325)
|
(175 395)
|
(165 765)
|
(154 620)
|
(140 235)
|
(134 071)
|
(135 628)
|
|
| Depreciation & Amortization |
(5 235)
|
(5 502)
|
(5 788)
|
(6 089)
|
(6 316)
|
(6 530)
|
(6 740)
|
(6 945)
|
(7 034)
|
(7 091)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(3 912)
|
(3 912)
|
(3 912)
|
0
|
0
|
0
|
|
| Operating Income |
97 935
N/A
|
93 232
-5%
|
96 383
+3%
|
109 906
+14%
|
112 435
+2%
|
130 494
+16%
|
146 906
+13%
|
246 599
+68%
|
245 939
0%
|
236 780
-4%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(3 295)
|
(6 183)
|
(8 440)
|
(9 721)
|
(8 793)
|
(6 694)
|
(4 035)
|
(3 939)
|
(220)
|
2 805
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(3 912)
|
0
|
0
|
0
|
604
|
(280)
|
(280)
|
|
| Gain/Loss on Disposition of Assets |
66
|
71
|
0
|
54
|
53
|
204
|
153
|
112
|
130
|
(26)
|
|
| Total Other Income |
(9 970)
|
(10 348)
|
961
|
838
|
1 030
|
1 231
|
711
|
(1 777)
|
(2 123)
|
(1 749)
|
|
| Pre-Tax Income |
84 736
N/A
|
76 772
-9%
|
88 904
+16%
|
97 165
+9%
|
104 724
+8%
|
125 236
+20%
|
143 735
+15%
|
241 598
+68%
|
243 448
+1%
|
237 530
-2%
|
|
| Net Income | |||||||||||
| Tax Provision |
(39 624)
|
(32 411)
|
(18 062)
|
(17 187)
|
(6 151)
|
(6 044)
|
(6 515)
|
(27 996)
|
(39 263)
|
(21 469)
|
|
| Income from Continuing Operations |
45 112
|
44 361
|
70 842
|
79 978
|
98 573
|
119 191
|
137 220
|
213 602
|
204 184
|
216 061
|
|
| Income to Minority Interest |
(16)
|
(69)
|
(151)
|
976
|
808
|
(146)
|
(1 123)
|
(1 081)
|
(1 942)
|
(3 273)
|
|
| Net Income (Common) |
45 096
N/A
|
44 292
-2%
|
70 692
+60%
|
80 953
+15%
|
99 381
+23%
|
119 045
+20%
|
136 097
+14%
|
212 521
+56%
|
202 243
-5%
|
212 788
+5%
|
|
| EPS (Diluted) |
3 657.68
N/A
|
3 602.56
-2%
|
5 785.8
+61%
|
6 294.06
+9%
|
7 780.95
+24%
|
9 328.28
+20%
|
10 673.55
+14%
|
16 704.14
+57%
|
15 920.17
-5%
|
16 777.88
+5%
|
|
You don't have any saved screeners yet
